In his first year back in the White House, President Trump has overhauled US drug policy, abandoning the Biden administration's public health strategies in favor of aggressive military actions against fentanyl trafficking. Experts warn that these changes, including deep cuts to treatment programs, could reverse recent declines in overdose deaths. The pivot includes designating fentanyl as a weapon of mass destruction and launching naval strikes on suspected drug boats.
President Donald Trump's return to office in 2025 marked a sharp turn in the US response to the fentanyl crisis. Dismantling initiatives from the Biden era, which experts say saved tens of thousands of lives through expanded treatment and harm reduction, Trump emphasized a "war" on drug cartels. During a July signing ceremony for the Halt Fentanyl Act, he declared, "From day one of the Trump administration we declared an all-out war on the dealers, smugglers, traffickers and cartels."
Biden's policies, including billions in federal spending on addiction care and Medicaid expansion, contributed to a nearly 27 percent drop in fatal overdoses in his final year, per provisional CDC data. Medications like buprenorphine and naloxone became more accessible, and diplomatic efforts with China curbed precursor chemical flows. "We've made gains. There are more people now being treated for substance use disorders," noted Richard Frank of the Brookings Institution.
Trump's administration, however, imposed tariffs on Canadian goods in February, citing smuggling—despite DEA data showing only 43 pounds seized at the northern border versus 21,100 pounds at the southern one. It classified fentanyl as a "weapon of mass destruction" in December and deployed National Guard troops along the US-Mexico border. Naval strikes targeted boats near Venezuela, with Defense Secretary Pete Hegseth claiming they deterred trafficking, though evidence linking them to fentanyl is lacking.
Budget moves froze $140 million in grants and cut roughly $1 trillion from Medicaid, including addiction programs. A July executive order criticized harm reduction as facilitating drug use. Critics like Regina LaBelle of Georgetown University warn, "The biggest risk really of increasing overdose deaths is the Medicaid cutbacks." Trump's pardons of figures like Ross Ulbricht and Larry Hoover have drawn accusations of mixed signals, as Jeffrey Singer of the Cato Institute observed: "There's a lot of mixed messages... which creates sort of chaos."
Actual overdose deaths peaked at about 115,000 in 2023 and fell to 76,500 by April 2025, contradicting Trump's inflated claims of hundreds of thousands annually. Researchers fear the militarized shift may not address root causes, with Mexico remaining the primary fentanyl source per the DEA's July 2025 assessment.
